Latest Exploration Partnerships News

Page 1 of 6
LCL Resources has added a second Rio Tinto-funded exploration program in Papua New Guinea, while completing a 5,598 line-kilometre survey at its Ono project. The deal could see Rio Tinto earn up to 80% of Liamu, leaving LCL with funded exposure to several undrilled targets and A$7.76 million in cash.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.
Ada Torres
Ada Torres
29 Oct 2026
Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.
Ada Torres
Ada Torres
25 Aug 2026
Prescient Therapeutics boosted enrolment in its PTX-100 Phase 2a trial to 28 patients and appointed Dr Rosalind Wilson as Chief Medical Officer, strengthening its clinical leadership as it advances targeted cancer therapies.
Ada Torres
Ada Torres
27 July 2026
RareX Limited’s latest metallurgical program at Cummins Range delivers a breakthrough 9.5x upgrade in rare earth concentrate grade and confirms a viable gallium by-product extraction pathway, setting the stage for integrated multi-element processing.
Maxwell Dee
Maxwell Dee
13 July 2026
Ingenia Communities is in discussions with Peet Limited and potential capital partners to extend its land lease portfolio beyond its current five-year plan, aiming to boost scale and financial flexibility.
Eva Park
Eva Park
10 July 2026
Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.
Ada Torres
Ada Torres
8 July 2026
CZR Resources has reported promising assay results from its 2026 drilling and sampling campaigns across its Pilbara projects, highlighting significant copper-gold mineralisation at Croydon and strong iron ore potential at Yarraloola.
Maxwell Dee
Maxwell Dee
8 July 2026
Chimeric Therapeutics has appointed Hawkesbury Partners to lead a strategic review aimed at exploring options to enhance shareholder value, reflecting concerns that its market cap undervalues its clinical assets and infrastructure.
Ada Torres
Ada Torres
1 July 2026
Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.
Ada Torres
Ada Torres
16 June 2026
Tiger Gold has finalised its option to acquire LCL Resources’ Colombian gold assets with a $4.5 million payment, bringing total cash consideration to $7.5 million and strengthening LCL’s balance sheet ahead of a formal transfer on 11 June 2026.
Maxwell Dee
Maxwell Dee
10 June 2026
Burley Minerals has reignited interest in its Chubb Lithium Project in Quebec following a lithium price uptick and promising drilling results revealing both spodumene and rare pollucite mineralisation. The company is weighing strategic options including further exploration, joint ventures, or sale.
Maxwell Dee
Maxwell Dee
23 Apr 2026

Browse the archive

Full archive